Guotai Guzheng Medicine A-A Mutual Fund (160219)

Overview

The Guotai Guzheng Medicine A-A Mutual Fund is a specialized investment vehicle concentrating on the health and pharmaceutical sectors, with a primary focus on providing investors with entry into the dynamic and lucrative medical field in China. By investing exclusively in companies listed in China, especially those within the A-shares market, it aims to leverage the burgeoning healthcare needs driven by an aging population and rapid urbanization. The fund targets a diversified portfolio that includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers, aiming to tap into significant growth opportunities within the industry. This strategic approach allows the Guotai Guzheng Medicine A-A Mutual Fund to not only offer an avenue for investment in cutting-edge medical innovations and essential advancements but also to support the growth and development of China's economy through the healthcare sector.

Products and Services

• Pharmaceutical Company Investments

  The fund selects leading pharmaceutical companies that demonstrate innovation and growth potential within the Chinese market. These investments focus on firms developing new drugs, treatments, and medical solutions, aiming to address the various health challenges and opportunities presented by the nation's demographic and urbanization trends.

• Biotechnology Firm Holdings

  By investing in biotechnology firms, the Guotai Guzheng Medicine A-A Mutual Fund taps into the sector at the forefront of medical science and innovation in China. These companies are engaged in the research and development of transformative biotechnological applications, including gene therapy, novel vaccines, and advanced diagnostics, which promise to revolutionize healthcare outcomes.

• Medical Device Manufacturer Shares

  The portfolio includes investments in manufacturers of medical devices and equipment, recognizing the critical role these technologies play in diagnosing, preventing, and treating diseases. This segment benefits from continuous advancements in medical technology, catering to increasing healthcare demands within China.

• Healthcare Provider Equities

  This component of the fund's portfolio focuses on healthcare providers, encompassing a broad range of services from hospital care to specialized treatments. Investment in this sector is driven by the expectation that China's healthcare services will continue to expand and evolve, in line with the growing needs of its population.